RecallRadar

FDA Drug recall D-0765-2026

PEMRYDI RTU(pemetrexed injection), 500 mg/50 mL (10 mg/mL), Single-dose vial, Rx only, Manufactured by: Zydus Lifesciences Limited, Ahmedab…

On 2026-08-26 the FDA classified a Class II recall of PEMRYDI RTU(pemetrexed injection), 500 mg/50 mL (10 mg/mL), Single-dose vial, Rx only, Manufactured by: Zydus Lifesciences Limited, Ahmedab… by Shilpa Medicare, citing discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0765-2026
ClassificationClass II
Statusongoing
Initiated2026-07-29
Published2026-08-26
Last updated2026-09-13 11:52 UTC
CompanyShilpa Medicare
DistributionUS

Product

PEMRYDI RTU(pemetrexed injection), 500 mg/50 mL (10 mg/mL), Single-dose vial, Rx only, Manufactured by: Zydus Lifesciences Limited, Ahmedabad, India; Distributed by: Amneal Pharmaceuticals LC, Bridgewater, NY 08807. NDC: 70121-2461-1

Reason

Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials

Identifiers

ndc70121-2453-1
ndc70121-2461-1
ndc70121-2462-1
code_infoLot: P400157, Exp 08/31/2026; Lot PA00047A, Exp 09/30/2027

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0765-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.